Nephrology News

Tolvaptan Offers Sustained Slowing of Renal Function Decline in ADPKD

Open-label extension study confirms disease-modifying effect on eGFR, but not total kidney volume growth.

By accepting you will be accessing a service provided by a third-party external to https://galencarepartners.com/

Request Information

Invalid Input
Invalid Input
Invalid Input
Invalid Input